The claim in circulation A statement now circulating within the human subjects protection regulated community is this: the primary recipient of an HHS award is always engaged in the research it funds, even when it does no human subjects work itself and…
For the next three weeks, the regulatory team at the HRP Group is tackling one of the most complicated and hotly debated Common Rule concepts: engagement. In one article each week, we work through the gray areas in OHRP’s institutional…
This final installment starts with animal research, where FDA’s move away from animal testing and new NIH requests for input could affect IACUC and Assurance practices. It then turns to additional items worth your attention, including comment opportunities on NIH’s…
Several rulemakings and policy efforts that could change how human subjects research is reviewed and overseen are in the pipeline but have not yet been published. The FDA items below come from the Unified Agenda, so treat the target dates…
The summer items in Reg Roundup 1.2 set the direction, and fall has brought more activity along the same lines. This installment covers NIH’s plan to rewrite its Policy for Data and Safety Monitoring, FDA’s new Rare Disease Framework Initiative,…
Several developments from this summer generated enough attention on their own in trade press, law firm alerts, and conference programming that most people in this field will have seen at least a headline about one of them. While you may…
Not every consequential federal development arrives as a headline. This article opens with four items that may have slipped past you, including a K-award change that does not take effect until 2027 and a new HHS rulemaking on graduate medical…
Our Reg Roundup covers a lot of ground in a short space. In a single edition you might see a final rule, a proposed rule that has not been published yet, a draft guidance, a request for public input, and…
New and updated FDA guidance documents, technical amendments and policy clarifications relevant to IRBs, IACUCs, investigators and research organizations.
Expanding HRP’s leadership in AI research oversight — Tamiko Eto joins the firm with over two decades of experience in human subjects research protections.